283 related articles for article (PubMed ID: 10194450)
1. ALK+ lymphoma: clinico-pathological findings and outcome.
Falini B; Pileri S; Zinzani PL; Carbone A; Zagonel V; Wolf-Peeters C; Verhoef G; Menestrina F; Todeschini G; Paulli M; Lazzarino M; Giardini R; Aiello A; Foss HD; Araujo I; Fizzotti M; Pelicci PG; Flenghi L; Martelli MF; Santucci A
Blood; 1999 Apr; 93(8):2697-706. PubMed ID: 10194450
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype.
Suzuki R; Kagami Y; Takeuchi K; Kami M; Okamoto M; Ichinohasama R; Mori N; Kojima M; Yoshino T; Yamabe H; Shiota M; Mori S; Ogura M; Hamajima N; Seto M; Suchi T; Morishima Y; Nakamura S
Blood; 2000 Nov; 96(9):2993-3000. PubMed ID: 11049976
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma.
Gascoyne RD; Aoun P; Wu D; Chhanabhai M; Skinnider BF; Greiner TC; Morris SW; Connors JM; Vose JM; Viswanatha DS; Coldman A; Weisenburger DD
Blood; 1999 Jun; 93(11):3913-21. PubMed ID: 10339500
[TBL] [Abstract][Full Text] [Related]
4. ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum.
Falini B; Bigerna B; Fizzotti M; Pulford K; Pileri SA; Delsol G; Carbone A; Paulli M; Magrini U; Menestrina F; Giardini R; Pilotti S; Mezzelani A; Ugolini B; Billi M; Pucciarini A; Pacini R; Pelicci PG; Flenghi L
Am J Pathol; 1998 Sep; 153(3):875-86. PubMed ID: 9736036
[TBL] [Abstract][Full Text] [Related]
5. Among diffuse large B-cell lymphomas, T-cell-rich/histiocyte-rich BCL and CD30+ anaplastic B-cell subtypes exhibit distinct clinical features.
Maes B; Anastasopoulou A; Kluin-Nelemans JC; Teodorovic I; Achten R; Carbone A; De Wolf-Peeters C;
Ann Oncol; 2001 Jun; 12(6):853-8. PubMed ID: 11484964
[TBL] [Abstract][Full Text] [Related]
6. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.
Drexler HG; Gignac SM; von Wasielewski R; Werner M; Dirks WG
Leukemia; 2000 Sep; 14(9):1533-59. PubMed ID: 10994999
[TBL] [Abstract][Full Text] [Related]
7. Anaplastic Large Cell Lymphoma.
Medeiros LJ; Elenitoba-Johnson KS
Am J Clin Pathol; 2007 May; 127(5):707-22. PubMed ID: 17511113
[TBL] [Abstract][Full Text] [Related]
8. Adverse effects of activated cytotoxic T lymphocytes on the clinical outcome of nodal anaplastic large cell lymphoma.
ten Berge RL; Dukers DF; Oudejans JJ; Pulford K; Ossenkoppele GJ; de Jong D; Miseré JF; Meijer CJ
Blood; 1999 Apr; 93(8):2688-96. PubMed ID: 10194449
[TBL] [Abstract][Full Text] [Related]
9. ALK-positive lymphoma: a single disease with a broad spectrum of morphology.
Benharroch D; Meguerian-Bedoyan Z; Lamant L; Amin C; Brugières L; Terrier-Lacombe MJ; Haralambieva E; Pulford K; Pileri S; Morris SW; Mason DY; Delsol G
Blood; 1998 Mar; 91(6):2076-84. PubMed ID: 9490693
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease.
Wellmann A; Otsuki T; Vogelbruch M; Clark HM; Jaffe ES; Raffeld M
Blood; 1995 Sep; 86(6):2321-8. PubMed ID: 7662979
[TBL] [Abstract][Full Text] [Related]
11. A case of anaplastic lymphoma kinase-positive anaplastic large cell lymphoma presenting with spontaneous splenic rupture: an extremely unusual presentation.
Hebeda KM; MacKenzie MA; van Krieken JH
Virchows Arch; 2000 Oct; 437(4):459-64. PubMed ID: 11097375
[TBL] [Abstract][Full Text] [Related]
12. ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified.
ten Berge RL; de Bruin PC; Oudejans JJ; Ossenkoppele GJ; van der Valk P; Meijer CJ
Histopathology; 2003 Nov; 43(5):462-9. PubMed ID: 14636272
[TBL] [Abstract][Full Text] [Related]
13. Morphological and phenotypic features in pediatric large cell lymphoma and their correlation with ALK expression and the t(2;5)(p23;q35) translocation.
Sherman CG; Zielenska M; Lorenzana AN; Pulford KA; Mason DY; Hutchison RE; Thorner PS
Pediatr Dev Pathol; 2001; 4(2):129-37. PubMed ID: 11178628
[TBL] [Abstract][Full Text] [Related]
14. Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas.
Haralambieva E; Pulford KA; Lamant L; Pileri S; Roncador G; Gatter KC; Delsol G; Mason DY
Br J Haematol; 2000 Jun; 109(3):584-91. PubMed ID: 10886208
[TBL] [Abstract][Full Text] [Related]
15. Clinical and laboratory characteristics of systemic anaplastic large cell lymphoma in Chinese patients.
Wang YF; Yang YL; Gao ZF; Zhou CJ; Gregg X; Shi YF; Wang J; Yang XF; Ke XY
J Hematol Oncol; 2012 Jul; 5():38. PubMed ID: 22769020
[TBL] [Abstract][Full Text] [Related]
16. Anaplastic large cell lymphoma, ALK-negative.
Ferreri AJ; Govi S; Pileri SA; Savage KJ
Crit Rev Oncol Hematol; 2013 Feb; 85(2):206-15. PubMed ID: 22789917
[TBL] [Abstract][Full Text] [Related]
17. Primary systemic anaplastic large-cell lymphoma (CD30+): advances in biology and current therapeutic approaches.
Fiorani C; Vinci G; Sacchi S; Bonaccorsi G; Artusi T
Clin Lymphoma; 2001 Jun; 2(1):29-37; discussion 38-9. PubMed ID: 11707867
[TBL] [Abstract][Full Text] [Related]
18. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1.
Pulford K; Lamant L; Morris SW; Butler LH; Wood KM; Stroud D; Delsol G; Mason DY
Blood; 1997 Feb; 89(4):1394-404. PubMed ID: 9028963
[TBL] [Abstract][Full Text] [Related]
19. Extra copies of chromosome 2 are a recurring aberration in ALK-negative lymphomas with anaplastic morphology.
Kansal R; Sait SN; Block AW; Ward PM; Kelly FL; Cheney RT; Czuczman M; Brecher ML; Barcos M
Mod Pathol; 2005 Feb; 18(2):235-43. PubMed ID: 15475930
[TBL] [Abstract][Full Text] [Related]
20. ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination.
ten Berge RL; Oudejans JJ; Ossenkoppele GJ; Pulford K; Willemze R; Falini B; Chott A; Meijer CJ
J Clin Pathol; 2000 Jun; 53(6):445-50. PubMed ID: 10911802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
